Replies to post #2904 on GTC Biotherapeutics (fka GTCB)

[julescat]

Any significance in the acknowledgement that revenue from Merrimack is in the budget for this year? I agree that emphasis on follow-on biologics is welcome.

[buddiet]

I only have a small position in this stock (2500 shares). Have been reading and enjoying this board for several months. Would you tell where I could do more reading on the subject of follow on biologics (I think that's the term)? Thanks for input from all contributors. Good job!

[biopearl]

Dew, I agree the CC was very encouraging with more irons in the fire than the past. If that was you asking the last question, and I think is was, the Merrimack information is very important and they have always been deliberately vague in the area. My question is that I am unsure as to what biogenerics refers to as well as follow on biologics. Does this mean the agents like Enbrel or Tysabri will lose patent protection and then be made by goats? Thanks, bp